Strategy

Strategy

We enable biotech and pharma executive teams to grow the company’s value by maximizing clinical outcomes and chances of success through improved business norms. For over 10 years, we helped our bio-pharma partners to overcome the challenges to successful drug development and achieved unparalleled business results by transferring our scientific expertise, operational practices and technology innovation to their organizations.

Examples include Phase 3 deal terms at the Phase 2 stage, achieving statistically significant efficacy data in Phase I, agreeing to an acquisition before study completion, Phase 2 study results being accepted by the FDA as a pivotal study.

In all our projects, we use our patented benchmarking libraries, analytics platform DYNAMIKA and expert advisory board to diligently design your trial and to choose the right biomarkers and endpoints so that we can accurately project costs and timelines, discover risks and identify potential regulatory issues or barriers to approval.

We understand that each trial needs to deliver scientifically credible data, which is often pivotal to any future developments of your assets as well as financial health of the company. This is a summary of the metrics on the results from our biotech and pharma clients.

CASE STUDIES

OUR EXPERT TEAM

IMG_20200624_105741
Dr. Olga Kubassova, PhD
Chief Executive Officer
Life Science Innovator, Venture Partner and Bio-Pharma Drug Development Strategist

Chief Excecutive Officer of IAG, with expertise in actively managing innovation in life science companies, asset positioning, strategy and capital.

Jan Lundberg_TB Alliance Board of Directors
Dr. Jan Lundberg, MD, PhD
Chair of Scientifc Advisory Board
Novel Drug Discovery and Development

Chair of IAG’s Scientifc Advisory Board and expert in global pharmaceutical R&D, developing treatments in immunology, neurology and oncology.

prostate-cancer-iag
Dr. Jamshid Dehmeshki, PhD
Chief Technology Officer
Expert in Imaging, AI and Machine Learning in Drug Development

IAG’s CTO and expert in medical image analysis, data mining, algorithm development, medical image and video processing, mathematical, stochastic and forecasting modelling and numerical analysis.

archimed-christophe-2_3
Christophe Berthoux, MD
Chairman
Biotech and Pharma Drug Development Strategy

Chairman of IAG and operating partner of ArchiMed, recognized commercial leader in clinical research sector, investor and strategist.

MichaelClark
Michael Clark, PMP
Chief Operating Officer
Building Teams and Scalling Capabilities to Deliver Global Scale Imaging Clinical Trials

IAG’s COO and drug development veteran with 20+ years of experience growing teams and scaling operations.

Richard
Richard Nichol
Chief Finance Officer
Financial, P&L and Investment Professional with 20+ years of Expertise in Life science Industry

IAG’s CFO and Investment Professional with 20+ years of Expertise in Life science Industry.

Sotirios-Bisdase-135x135
Prof. Sotirios Bisdas, MD, PhD
Head of Neuro-Oncology and Neurology

IAG’s Head of Neuro-Oncology and Neurology Clinical Research and use of AI for early drug efficacy assessment.

Mikael_Boesen_IA_crop_square-135x135
Prof. Mikael Boesen MD, PHD
Head of IAG's Musculoskeletal Imaging Research

IAG’s Head of musculoskeletal Clinical Research and use of AI for early drug efficacy assessment.

thumbnail_Diana_Foto
Dr. Diana Dupont-Roettger, PhD
Scientific Advisor
Imaging Clinical Research Expert

Member of IAG’s Scientific Advisory Board and neuro-oncology expert.

PET-MRI
Faiq Shaikh, MD
Scientific Advisor

Member of IAG’s Scientific Advisory Board and expert in molecular imaging and radiomics.

Henning_Bliddal-135x202
Prof. Henning Bliddal, MD, DMSc
Scientific Advisor
Clinical Osteoarthritis Expert

Member of IAG’s Scientific Advisory Board and lead in developing new treatments for osteoarthritis.

Dr.-Guillermo-Valenzuela-135x135
Dr. Guillermo Valenzuela, M.D., F.A.C.R.
Scientific Advisor
Clinical Rheumatology Expert

Member of IAG’s Scientific Advisory Board and lead in drug development for arthritic and rheumatic diseases.

MikkelOstergaard-ImageAnalysis-135x161
Prof. Mikkel Østergaard, MD, PhD, DMSc
Scientific Advisor
Imaging in Rheumatoid Arthritis Expert

Member of IAG’s Scientific Advisory Board and lead in drug development for rheumatic conditions.

Nikolay-135x135
Dr. Nikolay Tzaribachev, MD
Scientific Advisor
Paediatric Rheumatology Expert

Member of IAG’s Scientific Advisory Board and lead in pediatric rheumatology.

JohnCarrino-135x175
Dr. John Carrino, MD, MPH
Scientific Advisor
Musculoskeletal Imaging Expert

Member of IAG’s Scientific Advisory Board and lead in musculoskeletal clinical research.

UHealth Portraits-1633
Dr Ty K Subhawong
Scientific Advisor

Member of IAG’s Scientific Advisory Board and lead in musculoskeletal imaging of bone and soft tissue sarcoma.

Jeremy-Nettle-135x173
Jeremy Nettle
Non-Executive Director, Investor
Digital Disruption on the Healthcare Expert

NED and global client adviser for healthcare.

RobertKarl-MRI1-135x135
Robert Karl
Investment Director / Bio-Partnering
Investment Strategy and Capital for Life-Sciences Companies

Robert is heavily involved into building a diversified investment portfolio composed of early to market stage products.

Syed-Rahman1-135x135
Dr. Syed Rahman-Uddin
Scientific Advisor
Oncology Expert

Member of IAG’s Scientific Advisory Board and expert in oncology imaging.

Asim-Mian-135x148
Dr. Asim Mian
Scientific Advisor
Neuro-oncology Imaging Expert

Member of IAG’s Scientific Advisory Board and expert in neuro-radiology.

Francesco-135x118
Dr. Francesco Del Galdo
Scientific Advisor
Expert in Scleroderma Clinical Research

Member of IAG’s Scientific Advisory Board and expert in scleroderma clinical research.

CNNfaculty-Anderson111-135x137
Dr. Stephan Anderson, MD, PhD
Scientific Advisor
Thoraco-abdominal Imaging Expert

Member of IAG’s Scientific Advisory Board and expert in thoraco-abdominal imaging.

Malcolm-135x135
Dr. Malcolm Barratt-Johnson
Advisor
Regulatory Strategy Expert

Member of IAG’s Scientific Advisory Board and lead in medical and regulatory affairs.

Bob-Stein_RD_135
Dr. Robert Stein, MD, PhD
Scientific Advisor

Member of IAG’s Scientific Advisory Board and lead in oncology clinical research.

Pete-180x180
Dr. Peter Mitchell, PhD
Scientific Advisor

Member of IAG’s Scientific Advisory Board and lead in commercial pharmaceutical leadership focused on arthritis and inflammation.

Richard_Barker-135x206
Richard Barker, OBE
Scientific Advisor

Member of IAG’s Scientific Advisory Board, NED and lead in precision medicine clinical research.

download
Prof. Felix Eckstein
Scientific Advisor

Member of IAG’s Scientific Advisory Board and lead in assessment of degenerative changes in osteoarthritis.

Peter-135x135
Prof. Peter Taylor, MA, BM, BCh, FRCP, FRCPE
Scientific Advisor
Rheumatology Clinical Research Expert

Member of IAG’s Scientific Advisory Board and lead in biologic and small molecular therapies for rheumatic diseases.

pmease2
Prof. Mease Philip, MD
Scientific Advisor
Rheumatology Clinical Research Expert

Member of IAG’s Scientific Advisory Board and lead in emerging therapies and disease state metrics for rheumatic diseases.

HaniGabra-ImageAnalysis-135x180
Prof. Hani Gabra, MD
Scientific Advisor

Member of IAG’s Scientific Advisory Board and lead in ovarian cancer drug development and research.

ali-mobasheri
Prof. Ali Mobasheri
Scientific Advisor

Member of IAG’s Scientific Advisory Board and lead in musculoskeletal clinical research & biomarkers

JS2
Dr. John Howard Sampson, M.D., Ph.D, M.B.A, M.H.S.c
Scientific Advisor

Member of IAG’s Scientific Advisory Board and lead in brain tumor imaging.

download
Dr. Sven Kili, MD, PhD
Scientific Advisor

Member of IAG’s Scientific Advisory Board and lead in cell and gene drug development.

Ben Photo
Benjamin M. Ellingson, Ph.D.
Scientific Advisor
IAG's Radiology Expert and Opinion Leader in Brain Tumor Imaging

Member of IAG’s Scientific Advisory Board and lead in brain tumor imaging.

Michael Brun Andersen
Dr. Michael Brun Andersen
Scientific Advisor
IAG's Radiology Expert and Opinion Leader in Imaging for Lung Disease

Member of IAG’s Scientific Advisory Board and lead in imaging of lung (cancer, infection and pneumonia).

Screenshot 2020-05-03 at 13.57.14
Dr. Muhammad Ali Memon
Scientific Advisor
IAG's Ophtalmology Expert and Clinical Trials Fellow

Member of IAG’s Scientific Advisory Board and lead in ophtalmology (AMD, retinopathies, uveitis and other conditions of the eye).

nathalie
Nathalie Faye, MD, PhD
Scientific Advisor

Member of IAG’s Scientific Advisory Board and lead in solid tumor radiology.

fmulero
Francisca Mulero, MD, PhD
Scientific Advisor

Member of IAG’s Scientific Advisory Board and expert in medical scintigraphy and nuclear medicine.

mettemogensenscanner-3-681x1024
Mette Mogensen, MD, PhD
Scientific Advisor

Member of IAG’s Scientific Advisory Board and expert in skin imaging and dermatology (cutaneous lupus, melanoma and other skin diseases).

ECohen2
Dr. Sotirios Bisdas, MD, PhD
Scientific Advisor

Member of IAG’s Scientific Advisory Board and lead in oncology drug development.